Betaine + glycerol + salcaprozate sodium

Betaine + glycerol + salcaprozate sodium has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Oct 31, 2026: “A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin Penetration”.

Intervention

1 paper studies it4 findingsUpdated

1 new paper in 30 daysSee all 1 papers on betaine + glycerol + salcaprozate sodium

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Guangdong Provincial Department of Science and Technology and 2 more
  • Animals1

What did studies of betaine + glycerol + salcaprozate sodium find?

4

Studies of betaine + glycerol + salcaprozate sodium measured 4 outcomes, among them hyperglycemia, body-weight gain and semaglutide retention in skin.

Hyperglycemia

downin mice1

1 study
  1. Betaine + glycerol + salcaprozate sodium decreases hyperglycemia in mice (obese and diabetic mice).

    “In obese and diabetic mice, BGS effectively suppressed body weight gain and ameliorated hyperglycemia.”

    Animalsobese and diabetic mice

    A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin Penetration

    Pharmaceutics

More on Hyperglycemia

Body-weight gain

downin mice1

1 study
  1. Betaine + glycerol + salcaprozate sodium decreases body-weight gain in mice (obese and diabetic mice).

    “In obese and diabetic mice, BGS effectively suppressed body weight gain and ameliorated hyperglycemia.”

    Animalsobese and diabetic mice

    A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin Penetration

    Pharmaceutics

Semaglutide retention in skin

upin pigs1

1 study
  1. Betaine + glycerol + salcaprozate sodium increases semaglutide retention in skin in pigs (ex vivo; compared with phosphate-buffered saline) (86.34 ± 6.12 μg/cm2 at 24 h; approximately 4.51 times PBS).

    “BGS enhanced semaglutide penetration and accumulation, with the amount retained in skin reaching 86.34 ± 6.12 μg/cm2 at 24 h, approximately 4.51 times that with PBS.”

    Animalsex vivo; compared with phosphate-buffered salinedeep eutectic solventskin24 h

    A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin Penetration

    Pharmaceutics

Semaglutide aggregation

downin cells1

1 study
  1. Betaine + glycerol + salcaprozate sodium decreases semaglutide aggregation in cells (compared with phosphate-buffered saline; cell-free formulation assessment) (Peak particle size: 51.7 versus 125.9 nm in PBS).

    “The BGS drug delivery system markedly suppressed semaglutide aggregation, shifting the peak particle size from 125.9 nm in phosphate-buffered saline (PBS) to 51.7 nm.”

    Cellscompared with phosphate-buffered saline; cell-free formulation assessmentdeep eutectic solvent

    A Novel Salcaprozate Sodium Deep Eutectic System for Oral Semaglutide Delivery and Enhanced Skin Penetration

    Pharmaceutics

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months